MBIO · Mustang Bio, Inc.
Market Cap
$4.07M
Shares
7.58M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.54
Open$0.55
Day$0.53–0.55
52W close$0.54–1.77
Avg vol 30d28K
Short int53K · 0.7% float · 1.4d
Short vol40%
Last earningsAug 16, 2021
DataJan 2025–Aug 2026
Filing10-Q · Aug 5
Raw chart and full-history price indicators begin at the captured split on Jan 16, 2025; bars on opposite sides are not compared.
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Aug 5, 2026
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Strong Sell
Momentum
Very Weak
Sentiment
Bullish
Fundamentals
Fair
Quant / Vol
Very High
Market backdrop
VIX 14.4 · calm
Equity put/call 0.62
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−36%
below
Price vs 50-day avg
−14%
below
RSI (14)
36
neutral
MACD trend
Negative
52-week position
0%
near low
Momentum
relative strength
1-month return
−6%
trailing
6-month return
−42%
trailing
YTD return
−45%
this year
Relative strength
−55%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $1 › 200d $1 — 200d above 50d
Institutional flow
Accumulating
+5% holders QoQ · +5 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.69% of float · ▼ -4.7% MoM · 1.4 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
23 holders — mid 3-yr range
Squeeze score
32
low risk · 0–100
Fundamentals
EPS growth
+99%
Y/Y
Free cash flow
$-5.3M
Quant / Vol
risk profile
Volatility
68%
annualized · 1-yr
Max drawdown
−70%
past year
ATR
6.3%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Strong Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−36%
Bearish
Price vs 50-day avg
−14%
Bearish
RSI (14)
36
Neutral
MACD trend
Negative
Bearish
52-week position
0%
Bearish
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $1 › 200d $1 — 200d above 50d
Institutional flow
Accumulating
+5% holders QoQ · +5 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.69% of float · ▼ -4.7% MoM · 1.4 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
23 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $1
Now $1 · 0%
Range high $2
vs 200-day avg -36%
vs 50-day avg -14%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
MBIO
this stock
Mustang Bio, Inc.
|
$4.07M | -45.2% | — | — | 0.7% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$137.30B | +19.5% | +46.2% | 31.6 | 1.6% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$81.77B | +2.9% | +20.8% | 19.7 | 2.3% |
|
ARGX
Argenx SE
|
$63.63B | +21.7% | — | — | 1.9% |
|
CSLLY
Csl Ltd
|
$59.23B | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Earnings & Events
Performance
Raw-price comparisons begin at the captured split on Jan 16, 2025; windows that need an earlier baseline remain unavailable.
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| MBIO | -7.1% | -5.7% | -41.5% | -5.7% | -45.2% |
| SPY | +0.5% | +3.0% | +13.4% | +3.0% | +12.8% |
| vs SPY | -7.6% | -8.7% | -54.9% | -8.7% | -58.0% |
Key facts
CIK
1680048
CUSIP
62818Q302
13F (30d)
19 filings
19 filers
Visit website
Investor relations